Economic Burden of Lung Cancer Attributable to Smoking In China in 2015

Shi, Jufang; Liu, C; Ren, Jianwei; Huang, Huiyao; Wang, L; Parascandola, Mark; Wu, Ning; Zou, Xiaoting; Liu, G; Dai, Min

doi:10.1016/j.jval.2018.07.021

Cited by 9 publications

(13 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the present study, we also found that from 1990 to 2017, the mortality of lung cancer was increasing for both sexes in China but not in the US, which was consistent with a previous study reported that lung cancer mortality was decreasing in the US but rising in China [4]. The mortality of lung cancer attributable to smoking also has generally increased in China, which was possibly contributed to the high prevalence of smoking [8] and a large burden of tobacco assumption in China [9]. The mortality of lung cancer attributable to smoking has decreased in the US, which may be due to the decreasing smoking prevalence in the US.…”

Section: Discussionsupporting

confidence: 91%

See 1 more Smart Citation

The mortality of lung cancer attributable to smoking among adults in China and the United States during 1990–2017

Liu

Yan

Wang

et al. 2020

Cancer Communications

View full text Add to dashboard Cite

Background: Statistical data on the burden and relevant risk factors of lung cancer are valuable for policy-making. This study aimed to compare the mortality of lung cancer attributable to smoking stratified by sex and age among adults in China and the United States (US). Methods: We extracted age-standardized mortality rates of lung cancer during 1990-2017 using the comparative risk assessment framework of the 2017 Global Burden of Disease study. We performed an age-period-cohort analysis to estimate time trend of lung cancer mortality attributable to smoking. Results: During 1990-2017, the age-standardized mortality rate of lung cancer was increasing in China but decreasing in the US for both sexes. The mortality attributable to smoking in China showed a generally increasing trend, while a continuous decrease was observed in the US. The age-period-cohort analysis showed a similar trend of age effect among adults between China and the US: the mortality substantially increased from the 30-34 to 80-84 age group and subsequently decreased in the 90-94 age group. However, the period effect rapidly increased in Chinese adults during 1990-2017, while it tended to be stable in the US although it was still slightly increasing in women. The cohort effect generally peaked in the earlier cohort born in 1902-1906 in the two countries. Conclusions: During 1990-2017, the lung cancer mortality attributable to smoking and the period effect are generally increasing in Chinese adults; the mortality attributable to smoking is decreasing in the US adults, but the period effect tends to be stable. The rapid aging and prevalence of smoking may intensify the increasing mortality of lung cancer in China.

show abstract

Section: Discussionsupporting

confidence: 91%

“…However, the secular trends in lung cancer mortality attributable to smoking remain unknown in both China and the US, and more epidemiologic evidences on the effectiveness of tobacco control are needed. Smoking rate is rising in China [8], and the smoking‐related economy burden is still substantial in China [9].…”

Section: Introductionmentioning

confidence: 99%

The mortality of lung cancer attributable to smoking among adults in China and the United States during 1990–2017

Liu

Yan

Wang

et al. 2020

Cancer Communications

View full text Add to dashboard Cite

show abstract

“…Importantly, we rstly reported the signi cantly decreased expense based on ROSE in combination with EBUS biopsy. And we speculated that the reduction of expense during diagnosis would be responsible for the reduced cases including severe complications and the chance of second biopsy, which contributed to public health resources greatly [30].…”

Section: Discussionmentioning

confidence: 99%

Applicability of Endobronchial Ultrasound and Virtual Bronchoscopic Navigation Combined with Rapid On-Site Evaluation in Diagnosing Peripheral Lung Lesions

Liao

Zhao

et al. 2021

Preprint

View full text Add to dashboard Cite

Background To investigate the value of endobronchial ultrasound (EBUS) and virtual bronchoscopic navigation (VBN) combined with rapid on-site evaluation (ROSE) in diagnosing peripheral pulmonary lesions (PPLs). Methods Between January 1st 2019 to September 1st 2021, EBUS and VBN examination were performed in 250 consecutive patients with PPLs who were admitted to Zhangzhou Affiliated Hospital of Fujian Medical University (Fujian, China). Finally, 198 eligible patients were randomly divided into ROSE group (100 cases) and non-ROSE group (98 cases). The diagnostic yield of brushing and biopsy, the complications, the procedure time, the diagnosis time and expense during diagnosis were analyzed. Results In the ROSE group, the positive rate of EBUS brushing and biopsy were 68%, 84%, repectively. The average procedure time and diagnosis time were 18.6 ± 6.8 min, 3.84 ± 4.28 days, repectively, and the average expense was 4093.15 ± 4494.67 yuan. In the controls, the positive rate of brushing and biopsy were 44%, 74%, repectively. The average procedure time and diagnosis time were 15.4 ± 5.7 min, 6.46 ± 3.66 days, repectively. And the average expense during diagnosis was 6420.28 ± 4541.33 yuan. There was significant difference in the positive rate of EBUS brushing and biopsy, diagnosis time and expense during diagnosis between both groups. And no significant difference was observed in the complications and the procedure time. Additionally, the impact of ROSE on diagnostic yield in right upper lobe and the size of lesion ≤2 cm in diameter was significant. Conclusion In combination with ROSE, EBUS could significantly improve the positive rate of diagnosing PPLs, shorten diagnosis time and reduce expense during diagnosis. ROSE will be of great importance in the diagnosis of PPLs and medical resource.

show abstract

“…Shi et al found that the total estimated expenditure of lung cancer attributable to smoking in China in 2015 was US$5.249 billion, accounting for 0.79% of China's total healthcare expenditure. This expenditure is likely to increase given the current trends in lung cancer (10). In China, the economic burden of lung cancer attributable to Figure 3 The age-period-cohort results in the mortality rate of lung cancer attributable to smoking for both sexes (by sex) from 1990 to 2017.…”

Section: Discussionmentioning

confidence: 99%

“…In China, smoking habits and behaviors among the population have become more westernized (10). In 2019, the World Health Organization (WHO) reported estimates for the prevalence of smoking in all countries in response to the global tobacco epidemic (11).…”

Section: Introductionmentioning

confidence: 99%

A comparison of the burden of lung cancer attributable to tobacco exposure in China and the USA

Wu¹,

Zhu²,

Xu³

et al. 2020

Ann Transl Med

View full text Add to dashboard Cite

Background: Tobacco exposure (TE) is the major contributor to lung cancer mortality worldwide. This study aims to clarify the possible reasons underlying the long-term trends and differences in lung cancer mortality attributable to TE in China and the United States of America (USA).Methods: Lung cancer mortality data from China and the USA were obtained from the Global Burden of Disease (GBD) Study 2017. Joinpoint regression analysis was used to assess the magnitude and direction of trends from 1990 to 2017, and the age-period-cohort model (APCM) was used to analyze the temporal trends of lung cancer mortality by age, period, and cohort.Results: For lung cancer attributable to smoking, the age-standardized mortality rates (ASMRs) exhibited an upward trend in China and a downward trend in the USA. The overall net drifts per year were 0.72% for China and −3.03% for the USA, and the local drift values in China and the USA increased by age group. All cohort/period relative risks (RRs) increased in China but decreased in the USA. The longitudinal age curves increased rapidly in China, whereas those in the USA were rose gradually. For lung cancer attributable to secondhand smoke, the ASMRs showed a downward trend in both China and the USA. The overall net drifts per year were −0.48% for China and −3.97% for the USA, and the local drift values in China and the USA also increased by age group. Cohort/period RRs decreased in the USA, and fluctuated in China. The longitudinal age curve trends in China and the USA were similar to those of smoking. Conclusions:The dangers of TE in China remain serious. The rates of lung cancer mortality attributable to TE have increased, especially in older individuals. We recommend that China strengthens the implementation of effective targeted tobacco control policies and other interventions to reduce the burden of lung cancer.

show abstract

Economic Burden of Lung Cancer Attributable to Smoking In China in 2015

Cited by 9 publications

References 0 publications

The mortality of lung cancer attributable to smoking among adults in China and the United States during 1990–2017

The mortality of lung cancer attributable to smoking among adults in China and the United States during 1990–2017

Applicability of Endobronchial Ultrasound and Virtual Bronchoscopic Navigation Combined with Rapid On-Site Evaluation in Diagnosing Peripheral Lung Lesions

A comparison of the burden of lung cancer attributable to tobacco exposure in China and the USA

Contact Info

Product

Resources

About